HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Intra Selected Research

Neoplasms (Cancer)

7/2013Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study.
4/2011Safety of fat grafting in secondary breast reconstruction after cancer.
10/2010Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.
12/2007[Conservative approach for breast cancer. The experience of the European Institute of Oncology].
9/2006A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancer.
11/2004Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies.
12/2003Preoperative systemic treatment: prediction of responsiveness.
2/2002Very young women (<35 years) with operable breast cancer: features of disease at presentation.
11/2001A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated.
11/2001Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Intra Research Topics

Disease

27Breast Neoplasms (Breast Cancer)
03/2016 - 08/2000
12Neoplasms (Cancer)
07/2013 - 08/2000
3Carcinoma (Carcinomatosis)
01/2008 - 11/2001
2Neoplasm Metastasis (Metastasis)
06/2011 - 11/2001
2Residual Neoplasm
12/2003 - 11/2001
1Fibrosis (Cirrhosis)
08/2011
1Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2011
1Infections
04/2011
1Male Breast Neoplasms (Male Breast Cancer)
12/2007
1Lymphatic Metastasis
03/2007
1Contracture
01/2006
1Calcinosis
12/2005
1Noninfiltrating Intraductal Carcinoma (DCIS)
12/2005

Drug/Important Bio-Agent (IBA)

6Estrogen ReceptorsIBA
03/2013 - 08/2000
6Progesterone Receptors (Progesterone Receptor)IBA
03/2013 - 08/2000
4Phenobarbital (Luminal)FDA Link
03/2013 - 10/2010
2Biomarkers (Surrogate Marker)IBA
07/2013 - 11/2004
2AnthracyclinesIBA
09/2006 - 11/2001
2Cisplatin (Platino)FDA LinkGeneric
10/2003 - 11/2001
2Vinorelbine (Navelbine)FDA LinkGeneric
10/2003 - 11/2001
2Fluorouracil (Carac)FDA LinkGeneric
10/2003 - 11/2001
1TamoxifenFDA LinkGeneric
07/2013
1antineoplaston A10 (A 10)IBA
08/2011
1SolutionsIBA
04/2011
1Anti-Bacterial Agents (Antibiotics)IBA
04/2011
1human ERBB2 proteinIBA
10/2010
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2007
1Triptorelin Pamoate (Trelstar)FDA Link
09/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2006
1Taxoids (Taxanes)IBA
09/2006
1Letrozole (Femara)FDA LinkGeneric
09/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2006
1Docetaxel (Taxotere)FDA Link
09/2006
1Hormones (Hormone)IBA
08/2000
1Estrogens (Estrogen)FDA Link
08/2000

Therapy/Procedure

8Radiotherapy
08/2011 - 01/2001
8Drug Therapy (Chemotherapy)
07/2009 - 08/2000
6Therapeutics
06/2012 - 07/2001
5Segmental Mastectomy (Lumpectomy)
08/2011 - 11/2001
2Mammaplasty (Breast Reconstruction)
06/2013 - 04/2011
2Mastectomy (Mammectomy)
04/2011 - 12/2005
2Conservative Treatment
01/2006 - 01/2001
2ViFuP protocol
10/2003 - 11/2001
1Neoadjuvant Therapy
03/2016
1Myocutaneous Flap
04/2011
1Combined Modality Therapy
06/2008
1Contraindications
12/2007
1Breast Implants (Breast Implant)
01/2006